These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37111484)

  • 1. Antimicrobial Effects of Lactoferrin against
    Imoto I; Yasuma T; D'Alessandro-Gabazza CN; Oka S; Misaki M; Horiki N; Gabazza EC
    Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111484
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy.
    Zou J; Dong J; Yu XF
    Helicobacter; 2009 Apr; 14(2):119-27. PubMed ID: 19298339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota in the stomach and application of probiotics to gastroduodenal diseases.
    Koga Y
    World J Gastroenterol; 2022 Dec; 28(47):6702-6715. PubMed ID: 36620346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin sequestration and its contribution to iron-deficiency anemia in Helicobacter pylori-infected gastric mucosa.
    Choe YH; Oh YJ; Lee NG; Imoto I; Adachi Y; Toyoda N; Gabazza EC
    J Gastroenterol Hepatol; 2003 Aug; 18(8):980-5. PubMed ID: 12859729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic properties of bovine lactoferrin on Helicobacter pylori.
    Dial EJ; Hall LR; Serna H; Romero JJ; Fox JG; Lichtenberger LM
    Dig Dis Sci; 1998 Dec; 43(12):2750-6. PubMed ID: 9881510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.
    Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L
    Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of lactoferrin for Helicobacter pylori eradication. Preliminary results.
    Di Mario F; Aragona G; Bò ND; Ingegnoli A; Cavestro GM; Moussa AM; Iori V; Leandro G; Pilotto A; Franzè A
    J Clin Gastroenterol; 2003; 36(5):396-8. PubMed ID: 12702979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric juice levels of lactoferrin and Helicobacter pylori infection.
    Nakao K; Imoto I; Gabazza EC; Yamauchi K; Yamazaki N; Taguchi Y; Shibata T; Takaji S; Ikemura N; Misaki M
    Scand J Gastroenterol; 1997 Jun; 32(6):530-4. PubMed ID: 9200282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Decade Failure to the Eradication of Refractory
    Moghadam MT; Chegini Z; Norouzi A; Dousari AS; Shariati A
    Curr Pharm Biotechnol; 2021; 22(7):945-959. PubMed ID: 32767919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
    Di Mario F; Cavallaro LG; Nouvenne A; Stefani N; Cavestro GM; Iori V; Maino M; Comparato G; Fanigliulo L; Morana E; Pilotto A; Martelli L; Martelli M; Leandro G; Franzè A
    Helicobacter; 2007 Jun; 12(3):238-43. PubMed ID: 17493004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
    Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
    Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice.
    Huynh HQ; Campbell MA; Couper RT; Tran CD; Lawrence A; Butler RN
    Lett Appl Microbiol; 2009 May; 48(5):517-22. PubMed ID: 19187488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal microbiome and
    Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
    World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
    [No Abstract]   [Full Text] [Related]  

  • 16. Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection.
    Ohishi T; Masuda T; Abe H; Hayashi C; Adachi H; Ohba SI; Igarashi M; Watanabe T; Mimuro H; Amalia E; Inaoka DK; Mochizuki K; Kita K; Shibasaki M; Kawada M
    Helicobacter; 2018 Apr; 23(2):e12470. PubMed ID: 29488678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bovine lactoferrin for Helicobacter pylori eradication.
    Di Mario F; Aragona G; Dal Bò N; Cavestro GM; Cavallaro L; Iori V; Comparato G; Leandro G; Pilotto A; Franzè A
    Dig Liver Dis; 2003 Oct; 35(10):706-10. PubMed ID: 14620619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of
    Suzuki S; Esaki M; Kusano C; Ikehara H; Gotoda T
    World J Gastroenterol; 2019 Apr; 25(16):1907-1912. PubMed ID: 31086459
    [No Abstract]   [Full Text] [Related]  

  • 20. Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection.
    Guttner Y; Windsor HM; Viiala CH; Marshall BJ
    Aliment Pharmacol Ther; 2003 Jan; 17(1):125-9. PubMed ID: 12492741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.